A preliminary study showed that four weekly doses of intravenous rituximab, an anti-B-cell antibody, reduced proteinuria in patients with idiopathic membranous nephropathy, but individual ...

Rituxan (rituximab) is not safe to receive while pregnant or breastfeeding. Certain factors, including fetal harm, may determine whether you should receive the drug during this time. If you may be ...

Rituximab, hyaluronidase human 1400mg/23400 Units, 1600mg/26800 Units; soln for SC inj; preservative-free. Give by SC inj into abdomen. Premedicate with an antihistamine and acetaminophen prior to ...

“Subcutaneous rituximab can be administered in five to seven minutes compared to an hour and a half or more for intravenous Rituxan,” said Sandra Horning, M.D., chief medical officer and head ...

Intermittent stabilization could, however, be achieved with intravenous immunoglobulin ... To stabilize this condition we started rituximab therapy immediately after the third cycle of ...

We readmitted him and treated him with intravenous immunoglobulin, steroids, and added Rituximab to target the B cells producing these antibodies. The results were excellent — he improved ...

Targeted Oncology provides news, videos, and reviews on the rapidly evolving world of targeted therapies and immunotherapy ...

Immune effects of B-cell depletion by rituximab. Evidence that rituximab affects production of antibodies and regulation of immunoglobulin maturation by B cells includes reduced levels of IgM ...

The new formulation allows for an administration time lasting five to seven minutes, compared with the lengthy intravenous infusion with the older version branded as Rituxan in the US. With ...

intravenous globulin, plasma exchange, rituximab in life-threatening situations but based on limited evidence Prevent damage Minimize both damage due to systemic lupus erythematosus and as ...